+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gene Therapy"

Alopecia Areata- Pipeline Insight, 2025 - Product Thumbnail Image

Alopecia Areata- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Toll-Like Receptor Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

Toll-Like Receptor Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Psoriatic Arthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Alopecia - Pipeline Insight, 2025 - Product Thumbnail Image

Alopecia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Crohns Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Crohns Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
Gene Therapies For Cardiomyopathies - Pipeline Insight, 2025 - Product Thumbnail Image

Gene Therapies For Cardiomyopathies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Urticaria- Pipeline Insight, 2025 - Product Thumbnail Image

Urticaria- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Androgenetic Alopecia - Pipeline Insight, 2025 - Product Thumbnail Image

Androgenetic Alopecia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
NF-kappa B Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

NF-kappa B Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Uveitis - Pipeline Insight, 2025 - Product Thumbnail Image

Uveitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mucopolysaccharidosis III - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis III - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Kallikrein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Kallikrein Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Chronic Rhinosinusitis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Rhinosinusitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Chronic Otitis Media - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Otitis Media - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Seborrhoeic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Seborrhoeic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Mucopolysaccharidosis Type I- Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis Type I- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Wiskott-Aldrich Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Wiskott-Aldrich Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Inducible Urticaria - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Inducible Urticaria - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Lymphedema - Pipeline Insight, 2025 - Product Thumbnail Image

Lymphedema - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Loading Indicator

Gene therapy is a form of genomics that involves the introduction of genetic material into a patient's cells to treat or prevent a disease. It is a rapidly growing field of medicine, with the potential to revolutionize the treatment of genetic diseases. Gene therapy works by introducing a healthy gene into a patient's cells, replacing a defective gene or providing a missing gene. This can be done through a variety of methods, such as viral vectors, gene editing, and stem cell therapy. Gene therapy has the potential to provide long-term, curative treatments for a wide range of genetic diseases, including cancer, cystic fibrosis, and hemophilia. It is also being explored as a potential treatment for other conditions, such as Alzheimer's disease and Parkinson's disease. Gene therapy is a rapidly growing field, with many companies investing in research and development. Companies in the gene therapy market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Spark Therapeutics. Show Less Read more